Join PAH experts for a dynamic roundtable discussion examining why achieving low risk in the first year remains the therapeutic goal for most patients, as well as evaluating whether the partial success of intermediate-low risk is satisfactory
Through evidence-based discussion and real-world clinical experience, faculty will translate guideline-informed goals into real-world PAH care decisions
This is a disease education program sponsored by the PAH Initiative. No product information will be discussed.
Pulmonologist
Cardiologist
Pulmonologist
Pulmonologist
Clinical data linking early risk reduction with improved long-term outcomes
How frequent right heart evaluations can guide timely treatment decisions
How outcomes may differ when treatment goals are not achieved in the first year
This a non-CME credit event and does not qualify for CME, CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2026 conference sessions. This event is not endorsed by CHEST and does not reflect the views and opinions of CHEST.